The Swiss drug company will pay $40 a share in cash for California-based Chinook
Georg Schroeckenfuchs, head of Gulf and Saudi Country Group – Innovative Medicines at Novartis Innovation, tells us how technology is enabling innovation in healthcare
The MoU will enable Aster to access Novartis’ advanced therapy platforms and data science to further strengthen treatment outcomes for patients in the UAE